IART
Integra LifeSciences Holdings
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Integra LifeSciences (IART) Stock: Buy, Sell, or Hold?
$14.53
+0.16 (+1.11%)
▲
5d:
+6.6%
30d:
+3.93%
90d:
-16.4%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (19%)
Quality Score
40/100
Position
EXTENDED
30-Day Fair Range
$12.44 – $14.00
Position: EXTENDED
Forward P/E & Valuation
6.1x
FAIR
vs 5.5x historical avg
Wall Street Target
$15.67
+7.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$11.93 / $15.25
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: IART shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.92
Based on 2.8% avg growth
INTRINSIC VALUE TODAY
$9.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $14.53, which is considered extended relative to its 30-day fair value range of $12.44 to $14.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.1) compared to its historical average (5.5). At these levels, the market is pricing in 3.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a strong downtrend. Immediate support is located at $11.93, while resistance sits at $15.25.
Market Sentiment: IART scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IART is in a strong downtrend. Immediate support is located at $11.93, while resistance sits at $15.25.
Market Sentiment: IART scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.44 -
$14.00
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
19.0%
Trading Range & Key Levels
30-Day Trading Range
$12.44 -
$14.00
Current vs Trading Range
EXTENDED
Support Level
$11.93
Resistance Level
$15.25
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($15.67)
- BEARISH: Market expects 3.8% growth - appears too optimistic based on history
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
6.13
Wall Street Target
$15.67
(+7.8%)
Revenue Growth (YoY)
2.3%
Earnings Growth (YoY)
0.4%
Profit Margin
0.8%
Valuation Premium vs History
+3.8% premium
PE vs Historical
6.1 vs 5.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.8%
(market-implied from PE analysis)
1-Year Target
$15.08
(+4%)
2-Year Target
$15.66
(+8%)
3-Year Target
$16.25
(+12%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
PE COMPRESSION
$14.58
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 1.5%)
$49.16
(+238%)
Base:
(SPY PE: 6.1, Growth: 1.5%)
$15.18
(+5%)
Bear:
(PE: 5.2, Growth: 1.5%)
$12.90
(-11%)
📈
Valuation based on Current Earnings
Forward PE: 5.48 | Forward EPS (Implied): $2.65
Bull Case
$17.54
(+21%)
Analyst growth 15.0%, PE expands to 5.8
Base Case
$14.53
(0%)
Market implied 0.0%, PE stable at 5.5
Bear Case
$11.12
(-24%)
Severe decline -15.0%, PE contracts to 4.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share IART Analysis
Share this live IART analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IART)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors are bullish on $IART with expectations of a $20 price tag, according to a bullish StockTwits message. The latest news article from Yahoo Finance compares the value of $IART and $SONVY, with $IART having a lower forward P/E ratio and PEG ratio than $SONVY, making it potentially undervalued.
Key Retail Themes:
Positive earnings outlook
Undervalued status
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IART Research Pages
